Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Probiotic484 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A43005 | 32832510 | Hepatobiliary Surg Nutr | Probiotics and synbiotics targeting the intestinal microbiome attenuate non-alcoholic fatty liver disease. | 2020 | Details |
| A43034 | 32755308 | Am J Physiol Gastrointest Liver Physiol | Microbiota on biotics: probiotics, prebiotics, and synbiotics to optimize growth and metabolism. | 2020 | Details |
| A43035 | 32751062 | Int J Mol Sci | Consumption of Wild Rice (Zizania latifolia) Prevents Metabolic Associated Fatty Liver Disease through the Modulation of the Gut Microbiota in Mice Model. | 2020 | Details |
| A43057 | 32690129 | Gene Expr | Epidemiological Realities of Alcoholic Liver Disease: Global Burden, Research Trends, and Therapeutic Promise. | 2020 | Details |
| A43360 | 31909364 | J Obes Metab Syndr | Effect of Diet on the Gut Microbiota Associated with Obesity. | 2019 | Details |
| A43401 | 31823334 | Probiotics Antimicrob Proteins | Therapeutic and Nutritional Effects of Synbiotic Yogurts in Children and Adults: a Clinical Review. | 2020 | Details |
| A43488 | 31591781 | Aliment Pharmacol Ther | Letter: probiotics? Yes, but which ones? Authors' reply. | 2019 | Details |
| A43489 | 31591768 | Aliment Pharmacol Ther | Letter: probiotics? Yes, but which ones? | 2019 | Details |
| A43542 | 31464781 | Eur J Gastroenterol Hepatol | Bile acids and butyrate in the effects of probiotics/synbiotics on nonalcoholic fatty liver disease. | 2019 | Details |
| A43580 | 31356353 | Curr Opin Pediatr | The good bugs: the use of probiotics in pediatrics. | 2019 | Details |
| A43838 | 30741841 | J Clin Gastroenterol | Thirty Years of Lactobacillus rhamnosus GG: A Review. | 2019 | Details |
| A43843 | 30721959 | Adv Nutr | Mechanisms of Action of Probiotics. | 2019 | Details |
| A43951 | 30367438 | MMW Fortschr Med | [Gut-liver axis: How intestinal bacteria affect the liver]. | 2018 | Details |
| A44337 | 28936971 | Turk J Gastroenterol | Nonalcoholic steatohepatitis and gut microbiota: Future perspectives on probiotics in metabolic liver diseases. | 2017 | Details |
| A44341 | 28914862 | Ter Arkh | [Liver diseases: The pathogenetic role of the gut microbiome and the potential of treatment for its modulation]. | 2017 | Details |
| A44389 | 28736228 | Biochim Biophys Acta Gen Subj | DBZ is a putative PPARγ agonist that prevents high fat diet-induced obesity, insulin resistance and gut dysbiosis. | 2017 | Details |
| A44458 | 31089501 | J Obes Metab Syndr | The Roles of the Gut Microbiota and Toll-like Receptors in Obesity and Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A44680 | 27749611 | J Pediatr Gastroenterol Nutr | The Use of Probiotics in Pediatric Nonalcoholic Fatty Liver Disease: Teachable Moment or Missed Opportunity? | 2017 | Details |
| A44767 | 27366215 | Therap Adv Gastroenterol | Probiotics modify tight-junction proteins in an animal model of nonalcoholic fatty liver disease. | 2016 | Details |
| A45008 | 26447962 | J Clin Gastroenterol | Probiotics in Pediatric Liver Disease. | 2016 | Details |
| A45145 | 25922396 | Clin Infect Dis | New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics. | 2015 | Details |
| A45277 | 25436233 | ScientificWorldJournal | Is there a role for probiotics in liver disease? | 2014 | Details |
| A45380 | 24908907 | Fukuoka Igaku Zasshi | [Probiotic nutrition therapy for nonalcoholic fatty liver disease]. | 2014 | Details |
| A45450 | 24500146 | Am J Clin Nutr | More evidence that probiotics may have a role in treating fatty liver disease. | 2014 | Details |
| A45461 | 24445036 | J Nutr Biochem | Bifidobacterium adolescentis protects from the development of nonalcoholic steatohepatitis in a mouse model. | 2013 | Details |
| A45527 | 24130602 | Hepat Mon | More on current evidences on probiotics as a novel treatment for non-alcoholic Fatty liver disease. | 2013 | Details |
| A45571 | 23840101 | Mediators Inflamm | Influence of gut microbiota on subclinical inflammation and insulin resistance. | 2013 | Details |
| A45621 | 23610585 | Hepat Mon | Probiotic as a novel treatment strategy against liver disease. | 2013 | Details |
| A45685 | 23293210 | Ann Hepatol | Probiotics: a possible role in treatment of adult and pediatric non alcoholic fatty liver disease. | 2013 | Details |
| A45705 | 23177179 | Nutr Metab Cardiovasc Dis | Probiotics in the treatment of non alcoholic fatty liver disease: further evidence in obese children. | 2012 | Details |
| A45770 | 22848224 | Int J Microbiol | Microbial translocation in chronic liver diseases. | 2012 | Details |
| A45784 | 22763792 | Curr Gastroenterol Rep | Fighting fire with fire: is it time to use probiotics to manage pathogenic bacterial diseases? | 2012 | Details |
| A45922 | 22053380 | Zhonghua Gan Zang Bing Za Zhi | [Effect of microbial pharmaceutics on the function of NKT cells in rats with non-alcoholic steatohepatitis]. | 2011 | Details |
| A45965 | 21807932 | JPEN J Parenter Enteral Nutr | Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. | 2011 | Details |
| A45990 | 21710476 | Hepatology | Treatment implication from the potential association between nonalcoholic fatty liver disease and cardiovascular disease. | 2011 | Details |
| A46025 | 21505361 | J Pediatr Gastroenterol Nutr | Effects of Lactobacillus rhamnosus strain GG in pediatric obesity-related liver disease. | 2011 | Details |
| A46451 | 18542037 | J Clin Gastroenterol | Probiotics and liver disease. | 2008 | Details |
| A46610 | 17304406 | Z Gastroenterol | [News from the Cochrane Library: treatment of nonalcoholic fatty liver disease and steatohepatitis]. | 2007 | Details |
| A46845 | 12713883 | J Hepatol | Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics. | 2003 | Details |
| A46986 | 31241423 | J Am Coll Nutr | Hepatoprotective Effect of Probiotic Lactobacillus rhamnosus GG Through the Modulation of Gut Permeability and Inflammasomes in a Model of Alcoholic Liver Disease in Zebrafish. | 2019 | Details |
| A47004 | 30643227 | Nat Rev Gastroenterol Hepatol | Alcohol, liver disease and the gut microbiota. | 2019 | Details |
| A47078 | 26626356 | J Microbiol | Lactobacillus rhamnosus CCFM1107 treatment ameliorates alcohol-induced liver injury in a mouse model of chronic alcohol feeding. | 2015 | Details |
| A47118 | 25622859 | J Nutr Biochem | Enhanced AMPK phosphorylation contributes to the beneficial effects of Lactobacillus rhamnosus GG supernatant on chronic-alcohol-induced fatty liver disease. | 2014 | Details |
| A47146 | 24930470 | Alcohol Clin Exp Res | Pyrroloquinoline quinone-secreting probiotic Escherichia coli Nissle 1917 ameliorates ethanol-induced oxidative damage and hyperlipidemia in rats. | 2014 | Details |
| A47199 | 23206305 | Zhonghua Gan Zang Bing Za Zhi | [Changes in the intestinal microenvironment during development of alcoholic fatty liver disease and related effects of probiotic therapy]. | 2012 | Details |
| A47273 | 19645728 | Alcohol Clin Exp Res | Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats. | 2009 | Details |
| A48231 | 19145826 | Lik Sprava | [Clinical and biochemical characteristics of clinical course and management of patients with chronic nonalcoholic steatohepatitis in combination with intestinal diseases]. | 2009 | Details |
| A48349 | 15703634 | Curr Opin Gastroenterol | Nutritional supplements and alternative medicine. | 2004 | Details |
| A48556 | 34159177 | Hepatobiliary Surg Nutr | Are probiotics effective in reversing non-alcoholic steatohepatitis? | 2021 | Details |
| A48691 | 31405111 | Medicina (Kaunas) | Targeting Microbiota: What Do We Know about It at Present? | 2019 | Details |
| A48754 | 29687200 | Probiotics Antimicrob Proteins | Are Probiotics Effective in Targeting Alcoholic Liver Diseases? | 2019 | Details |
| A48883 | 25746479 | Toxicol Lett | Inhibition of miR122a by Lactobacillus rhamnosus GG culture supernatant increases intestinal occludin expression and protects mice from alcoholic liver disease. | 2015 | Details |
| A48938 | 23848072 | Nutr Hosp | [Probiotics in liver diseases]. | 2014 | Details |
| A48992 | 22165611 | MMW Fortschr Med | [Naturopathy consultation. Fatty liver and non-alcoholic steatohepatitis]. | 2011 | Details |
| A48996 | 21995448 | Microb Cell Fact | Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. | 2011 | Details |
| A49002 | 21734800 | World J Gastroenterol | Probiotics in hepatology. | 2011 | Details |
| A49413 | 35758473 | J Pediatr Gastroenterol Nutr | The benefit of probiotics in pediatric non-alcoholic fatty liver disease: a meta-analysis of randomized control trials. | 2022 | Details |
| A49552 | 35717780 | Biomed Pharmacother | Postbiotics as potential new therapeutic agents for metabolic disorders management. | 2022 | Details |
| A49606 | 35693397 | Hepatobiliary Surg Nutr | Extrahepatic organs in the development of non-alcoholic fatty liver disease in liver transplant patients. | 2022 | Details |
| A49627 | 35685888 | Front Nutr | Probiotic Therapy With VSL#3® in Patients With NAFLD: A Randomized Clinical Trial. | 2022 | Details |
| A49655 | 35677540 | Front Nutr | Effect of Probiotics on Liver Enzymes in Patients With Non-alcoholic Fatty Liver Disease: An Umbrella of Systematic Review and Meta-Analysis. | 2022 | Details |
| A49665 | 35677177 | Comput Math Methods Med | Effect of Probiotics Therapy on Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A49690 | 35669067 | Front Nutr | Effects of Synbiotics, Probiotics, and Prebiotics on Liver Enzymes of Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis. | 2022 | Details |
| A49755 | 35646285 | World J Gastrointest Oncol | Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics. | 2022 | Details |
| A50003 | 35565930 | Nutrients | Bifidobacterium animalis ssp. lactis MG741 Reduces Body Weight and Ameliorates Nonalcoholic Fatty Liver Disease via Improving the Gut Permeability and Amelioration of Inflammatory Cytokines. | 2022 | Details |
| A50160 | 35499800 | Biol Trace Elem Res | Selenium-Enriched Probiotic Alleviates Western Diet-Induced Non-alcoholic Fatty Liver Disease in Rats via Modulation of Autophagy Through AMPK/SIRT-1 Pathway. | 2022 | Details |
| A50198 | 35479741 | Front Nutr | Hepatoprotection of Probiotics Against Non-Alcoholic Fatty Liver Disease in vivo: A Systematic Review. | 2022 | Details |
| A50292 | 35442322 | Arq Gastroenterol | PROBIOTIC, PREBIOTIC OR SYMBIOTIC SUPPLEMENTATION IMPACTS ON INTESTINAL MICROBIOTA IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE: A SYSTEMATIC REVIEW. | 2022 | Details |
| A50462 | 35381910 | Surg Case Rep | Nonalcoholic fatty liver disease developed after pancreatoduodenectomy for solid pseudopapillary neoplasm in a 10-year-old girl: a case report. | 2022 | Details |
| A50491 | 35366201 | Ir J Med Sci | Comparative efficacy of exercise training processes in improving nonalcoholic fatty liver disease: a systematic review and meta-analysis. | 2022 | Details |
| A50599 | 35328587 | Int J Mol Sci | Usefulness of Probiotics in the Management of NAFLD: Evidence and Involved Mechanisms of Action from Preclinical and Human Models. | 2022 | Details |
| A50787 | 35266816 | mBio | Interleukin-17 Weakens the NAFLD/NASH Process by Facilitating Intestinal Barrier Restoration Depending on the Gut Microbiota. | 2022 | Details |
| A50963 | 35559112 | RSC Adv | Proteomics for studying the effects of L. rhamnosus LV108 against non-alcoholic fatty liver disease in rats. | 2018 | Details |
| A51110 | 35723657 | Child Obes | Probiotic Use in Children and Adolescents with Overweight or Obesity: A Scoping Review. | 2022 | Details |
| A51718 | 34630882 | World J Hepatol | Probiotics in hepatology: An update. | 2021 | Details |
| A51828 | 33874858 | Gut Microbes | Butyrate-producing human gut symbiont, Clostridium butyricum, and its role in health and disease. | 2022 | Details |
| A51962 | 32864127 | J Anim Sci Biotechnol | Role of nutraceuticals during the transition period of dairy cows: a review. | 2020 | Details |
| A52201 | 30153290 | PLoS One | Cholesterol-lowering effect of Lactobacillus rhamnosus BFE5264 and its influence on the gut microbiome and propionate level in a murine model. | 2018 | Details |
| A52302 | 28892150 | J Pathol | Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation. | 2017 | Details |
| A52398 | 27633133 | Endocrinol Nutr | An update on probiotics, prebiotics and symbiotics in clinical nutrition. | 2016 | Details |
| A52415 | 29889427 | Eksp Klin Gastroenterol | EFFECT OF CARBOXYLIC ACIDS OF GUT MICROBIAL ORIGIN ON HOST CELL PROLIFERATION IN ORGANOTYPIC TISSUE CULTURES. | 2016 | Details |
| A52544 | 25749935 | J Physiol Biochem | Gut microbiota: a key player in health and disease. A review focused on obesity. | 2015 | Details |
| A52579 | 25407511 | BMC Gastroenterol | Intestinal permeability--a new target for disease prevention and therapy. | 2014 | Details |
| A52586 | 25349631 | Gut Pathog | Whole-genome sequence assembly of Pediococcus pentosaceus LI05 (CGMCC 7049) from the human gastrointestinal tract and comparative analysis with representative sequences from three food-borne strains. | 2014 | Details |